Technical Analysis for CARM - Carisma Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.40 | -4.11% | -0.06 |
CARM closed down 4.11 percent on Wednesday, May 15, 2024, on 1.32 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -4.11% | |
| Oversold Stochastic | Weakness | -4.11% | |
| Lower Bollinger Band Touch | Weakness | -5.41% |
| Alert | Time |
|---|---|
| Down 5% | about 11 hours ago |
| Fell Below Lower Bollinger Band | about 11 hours ago |
| Down 3% | about 12 hours ago |
| Down 2 % | about 15 hours ago |
| New 52 Week Low | about 15 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania*, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Solid Tumors Immune System Cell Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Antigen Induced Stem Cells
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Solid Tumors Immune System Cell Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Antigen Induced Stem Cells
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.7662 |
| 52 Week Low | 1.345 |
| Average Volume | 168,418 |
| 200-Day Moving Average | 3.14 |
| 50-Day Moving Average | 1.96 |
| 20-Day Moving Average | 1.60 |
| 10-Day Moving Average | 1.52 |
| Average True Range | 0.12 |
| RSI (14) | 27.01 |
| ADX | 38.02 |
| +DI | 8.51 |
| -DI | 29.21 |
| Chandelier Exit (Long, 3 ATRs) | 1.55 |
| Chandelier Exit (Short, 3 ATRs) | 1.70 |
| Upper Bollinger Bands | 1.81 |
| Lower Bollinger Band | 1.40 |
| Percent B (%b) | 0.01 |
| BandWidth | 25.83 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.63 | ||||
| Resistance 3 (R3) | 1.64 | 1.57 | 1.59 | ||
| Resistance 2 (R2) | 1.57 | 1.51 | 1.57 | 1.58 | |
| Resistance 1 (R1) | 1.49 | 1.47 | 1.45 | 1.48 | 1.57 |
| Pivot Point | 1.42 | 1.42 | 1.40 | 1.41 | 1.42 |
| Support 1 (S1) | 1.33 | 1.36 | 1.30 | 1.32 | 1.23 |
| Support 2 (S2) | 1.26 | 1.32 | 1.26 | 1.22 | |
| Support 3 (S3) | 1.18 | 1.26 | 1.21 | ||
| Support 4 (S4) | 1.17 |
